Reduced dosing of enoxaparin for venous thromboembolism in overweight and obese adolescents: a single institution retrospective review

ESSENTIALS: Data is scarce on enoxaparin dosing for obese adolescents with venous thromboembolism (VTE). Overweight and obese adolescents treated with reduced enoxaparin dose (RD) were reviewed. Initial enoxaparin doses calculated using actual body weight may be greater than what is needed. Trials a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffman, Stephanie, Braunreiter, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058273/
https://www.ncbi.nlm.nih.gov/pubmed/30046689
http://dx.doi.org/10.1002/rth2.12032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058273/
https://www.ncbi.nlm.nih.gov/pubmed/30046689
http://dx.doi.org/10.1002/rth2.12032

Ejemplares similares